Page 2 - Nasdaq Cocp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq cocp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Cocp Today - Breaking & Trending Today

Short Interest in Cocrystal Pharma, Inc. (NASDAQ:COCP) Drops By 51.4%

Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Free Report) was the target of a large decline in short interest in September. As of September 15th, there was short interest totalling 7,100 shares, a decline of 51.4% from the August 31st total of 14,600 shares. Approximately 0.1% of the company’s shares are short sold. Based on an […] ....

Cocrystal Pharma , Susquehanna International Group , Cocrystal Pharma Company Profile , Cocrystal Pharma Inc , Exchange Commission , Get Free Report , International Group , Free Report , Pharma Stock Down , Cocrystal Pharma Daily , Nasdaq Cocp ,

Cocrystal Pharma, Inc. (NASDAQ:COCP) to Post Q3 2023 Earnings of ($0.45) Per Share, HC Wainwright Forecasts

Cocrystal Pharma, Inc. (NASDAQ:COCP – Free Report) – Research analysts at HC Wainwright increased their Q3 2023 earnings per share (EPS) estimates for Cocrystal Pharma in a research report issued on Tuesday, August 15th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings per share of ($0.45) for the quarter, up […] ....

Cocrystal Pharma , Exchange Commission , Renaissance Technologies , Cocrystal Pharma Inc , Free Report , Pharma Trading Down , Get Free Report , Cocrystal Pharma Daily , Nasdaq Cocp , Earnings Estimates , Hc Wainwright ,

Cocrystal Pharma (NASDAQ:COCP) PT Lowered to $12.00 at HC Wainwright

Cocrystal Pharma (NASDAQ:COCP – Get Rating) had its price objective lowered by HC Wainwright from $35.00 to $12.00 in a research note released on Wednesday morning, The Fly reports. HC Wainwright also issued estimates for Cocrystal Pharma’s Q2 2023 earnings at ($0.58) EPS, Q3 2023 earnings at ($0.54) EPS, Q4 2023 earnings at ($0.56) EPS, […] ....

Cocrystal Pharma , Cocrystal Pharma Company Profile , Renaissance Technologies , Cocrystal Pharma Inc , Exchange Commission , Get Rating , Director Phillip Md Et Al Frost , Cocrystal Pharma Daily , Nasdaq Cocp , Lower Price Target , Hc Wainwright ,

Cocrystal Pharma, Inc. (NASDAQ:COCP) Short Interest Up 163.2% in March

Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Rating) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 5,000 shares, a growth of 163.2% from the March 15th total of 1,900 shares. Based on an average daily volume of 84,700 shares, the short-interest ratio is […] ....

Cocrystal Pharma , Cocrystal Pharma Inc , Securities Exchange Commission , Get Rating , Director Phillip Md Et Al Frost , Exchange Commission , Cocrystal Pharma Daily , Nasdaq Cocp ,

Cocrystal Pharma, Inc. (NASDAQ:COCP) Director Buys $2,000,001.13 in Stock

Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Rating) Director Phillip Md Et Al Frost purchased 1,015,229 shares of the stock in a transaction that occurred on Tuesday, April 4th. The stock was acquired at an average cost of $1.97 per share, for a total transaction of $2,000,001.13. Following the completion of the acquisition, the director now […] ....

Cocrystal Pharma , Cocrystal Pharma Inc , Securities Exchange Commission , Get Rating , Director Phillip Md Et Al Frost , Exchange Commission , Pharma Trading Down , Cocrystal Pharma Daily , Nasdaq Cocp , Insider Trading , Nsider Trades ,